Do You Have to Increase Your Wegovy Dose?

Is stepping up the dose compulsory, or just the usual plan?

The titration schedule for Wegovy (semaglutide) is a clinical guide, not a countdown. The journey runs 0.25mg, then 0.5mg, then 1.0mg, then 1.7mg, and finally 2.4mg, each step held for roughly four weeks. The purpose of that slow climb is to let your gut adapt, nausea and other gastrointestinal effects are most likely when semaglutide is new to your system or when a dose increases. Slowing the pace reduces how disruptive that adjustment feels.

What the schedule does not do is obligate your prescriber to keep moving you forward on a fixed timetable. If you are losing weight steadily, feeling well on your current dose and finding side effects manageable, staying where you are is a legitimate clinical decision. The full range of Wegovy doses exists to give prescribers flexibility, not to set an endpoint everyone must reach.

The NHS semaglutide medicines page makes clear that dose changes are always guided by a healthcare professional and never something to adjust independently. That principle holds whether you are considering moving up, staying put or stepping back down after a difficult patch.

What happens if side effects make increasing the dose difficult?

Gastrointestinal symptoms (nausea, loose stools, indigestion, sometimes vomiting) are the most common reason people hesitate before a dose increase, and they are a sound reason to pause. Your prescriber can extend the time you spend at a lower dose until things settle, or hold indefinitely if that is what your health needs.

Some people find that keeping the pen in the fridge door where they see it every morning makes the weekly routine easier to maintain consistently, which in turn helps them track how their body is responding across weeks rather than just the day after an injection.

Stepping back to a lower dose after a difficult increase is also possible. It is not a failure; it is a dose adjustment. Clinical guidance acknowledges that not every patient will reach, or need to reach, the highest maintenance dose. A question our prescribers hear regularly is whether "going backwards" means starting over, it does not. You are still on treatment, still being monitored, and still making progress if your weight is responding.

The decision about whether to increase your dose depends on how much weight you have lost so far, how you have tolerated each step, and your wider health picture, factors only a prescriber reviewing your case can properly weigh.

Does skipping an increase mean the treatment stops working?

Not necessarily. Higher doses of semaglutide are associated with greater average weight loss in clinical trials, and the STEP 1 trial, published in the New England Journal of Medicine, found around 15% average body-weight reduction over 68 weeks at 2.4mg. But averages describe populations, not individuals. Some people achieve clinically meaningful weight loss at lower doses and maintain it comfortably.

NICE's appraisal of semaglutide for weight management notes that treatment should be reviewed if less than 5% weight loss has occurred after six months at the highest tolerated dose. That wording is significant: "highest tolerated", not highest possible. The guidance already builds in the reality that the top dose is not suitable for everyone.

If your weight loss has slowed significantly and you are well below any maintenance dose, a conversation about titration is worth having. If you are losing weight, feeling stable and tolerating your current dose, your prescriber may see no clinical reason to push further. These are not decisions to make from a forum; they belong in a proper clinical review, where someone can look at your actual numbers.

For a broader sense of how titration fits into the treatment journey, the timing of dose increases is worth reading alongside this page.

What if you want to increase, how does that work through a regulated service?

Requesting a dose increase is not as simple as ticking a box. Any reputable prescriber will want evidence that you are tolerating your current dose, have been on it for the recommended minimum period, and are progressing appropriately. At a GPhC-registered pharmacy, your notes, weight trend and any reported side effects are reviewed before a higher dose is supplied.

The clinical factors that govern dose progression include how long you have been at your current step, your weight response, and whether there are any new health considerations. A prescriber also looks at whether you are meeting the lifestyle recommendations that form part of the licensed indication, and if you are unsure whether your progress justifies moving up, our page on whether you need to increase your Wegovy dose can help you think through the question before your next clinical review. Semaglutide is approved alongside a reduced-calorie diet and increased physical activity, not instead of them.

If you are thinking about starting semaglutide or are mid-treatment and wondering whether your current plan needs a clinical conversation, checking your eligibility with our prescribers is the right first step. There is no pressure to move to a higher dose; the aim is to find the dose that works safely for you, for as long as you need it.